Synergetic cytotoxic activity toward breast cancer cells enhanced by the combination of Antp-TPR hybrid peptide targeting Hsp90 and Hsp70-targeted peptide

Abstract

BackgroundHeat shock protein (Hsp) 90 and Hsp70 are indispensable for cell survival under conditions of stress. They bind to client proteins to assist in protein stabilization, translocation of polypeptides across the cell membrane, and recovery of proteins from aggregates in the cell. Therefore, these proteins have recently emerged as important targets in the treatment of cancer. We previously reported that the newly designed Antp-TPR hybrid peptide targeting Hsp90 induced cytotoxic activity to cancer cells both in vitro and in vivo.MethodsTo further improve the cytotoxic activity of Antp-TPR toward cancer cells, we investigated the effect of a Hsp70-targeted peptide, which was made cell-permeable by adding the polyarginine with a linker sequence, on the cytotoxic activity of Antp-TPR in breast cancer cell lines.ResultsIt was revealed that Antp-TPR in the presence of a Hsp70-targeted peptide induced effective cytotoxic activity toward breast cancer cells through the descrease of Hsp90 client proteins such as p53, Akt, and cRaf. Moreover, the combined treatment with these peptides did not induce the up-regulation of Hsp70 protein, as determined by western blotting, a promoter assay using a luminometer, and single-cell level imaging with the LV200 system, although a small-molecule inhibitor of Hsp90, 17-allylamino-demethoxygeldanamycin (17-AAG), did induce the up-regulation of this protein. We also found that treatment with Antp-TPR, Hsp70-targeted peptide, or a combination of the two did not induce an increase in the glutathione concentrations in the cancer cells.ConclusionThese findings suggest that targeting both Hsp90 and Hsp70 with Antp-TPR and Hsp70-targeted peptide is an attractive approach for selective cancer cell killing that might provide potent and selective therapeutic options for the treatment of cancer.Electronic supplementary materialThe online version of this article (doi:10.1186/1471-2407-14-615) contains supplementary material, which is available to authorized users.

A study on the biological function of heat shock factor 1 proteins in breast cancer

“…The results revealed that the expression of HSP70, HSP90, anti-apoptotic Bcl-2 proteins, pro-apoptotic Bax proteins and MIFs in the two groups were significantly different. HSP70 and HSP90 are two important HSPs and one of the target proteins of HSF1, which are currently found to be highly expressed in many tumor tissues for promoting tumor development and metastasis ( 19 , 20 ). Anti-apoptotic Bcl-2 proteins and pro-apoptotic Bax proteins are the key proteins determining the fate of cells, and Bcl-2/Bax ratio variation determines the cells' tendency to apoptosis or normality ( 21 ).…”

In vivo therapeutic evaluation of polymeric nanomedicines: effect of different targeting peptides on therapeutic efficacy against breast cancer

“… 14 - 17 Therefore, targeting and potentially inhibiting HSP70 is a promising strategy in cancer therapy. 18 Rérole and coworkers have investigated a library of small peptide-aptamers and found a number of potential candidates that exhibited high affinity for HSP70, as well as enhanced chemo-sensitization. 19 Thus, these aptamers show significant potential as a therapeutic strategy for overcoming multidrug resistance.…”

Knockdown of microRNA-29a Changes the Expression of Heat Shock Proteins in Breast Carcinoma MCF-7 Cells

“…miRNAs dysregulation in human cancer came from molecular studies characterizing the loss of chromosomal region 13q14 in human chronic lymphocytic leukemia (CLL) ( 11 ), which revealed that two miRNAs, mir-15a and mir-16-1, were clustered within this chromosomal region ( 12 ). Following the first finding, miRNA dysregulation has been reported in various cancers.…”